Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias
- PMID: 18287270
- PMCID: PMC3703818
- DOI: 10.2967/jnumed.107.045385
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias
Abstract
This multicenter study examined (18)F-FDG PET measures in the differential diagnosis of Alzheimer's disease (AD), frontotemporal dementia (FTD), and dementia with Lewy bodies (DLB) from normal aging and from each other and the relation of disease-specific patterns to mild cognitive impairment (MCI).
Methods: We examined the (18)F-FDG PET scans of 548 subjects, including 110 healthy elderly individuals ("normals" or NLs), 114 MCI, 199 AD, 98 FTD, and 27 DLB patients, collected at 7 participating centers. Individual PET scans were Z scored using automated voxel-based comparison with generation of disease-specific patterns of cortical and hippocampal (18)F-FDG uptake that were then applied to characterize MCI.
Results: Standardized disease-specific PET patterns were developed that correctly classified 95% AD, 92% DLB, 94% FTD, and 94% NL. MCI patients showed primarily posterior cingulate cortex and hippocampal hypometabolism (81%), whereas neocortical abnormalities varied according to neuropsychological profiles. An AD PET pattern was observed in 79% MCI with deficits in multiple cognitive domains and 31% amnesic MCI. (18)F-FDG PET heterogeneity in MCI with nonmemory deficits ranged from absent hypometabolism to FTD and DLB PET patterns.
Conclusion: Standardized automated analysis of (18)F-FDG PET scans may provide an objective and sensitive support to the clinical diagnosis in early dementia.
Figures
Similar articles
-
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.Neuroimage Clin. 2018 Jan 28;18:167-177. doi: 10.1016/j.nicl.2018.01.019. eCollection 2018. Neuroimage Clin. 2018. PMID: 29387532 Free PMC article.
-
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2. Cochrane Database Syst Rev. 2015. PMID: 25629415 Free PMC article. Review.
-
(18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease.J Nucl Med. 2007 Jul;48(7):1129-34. doi: 10.2967/jnumed.107.040675. Epub 2007 Jun 15. J Nucl Med. 2007. PMID: 17574982
-
The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.J Neuroimaging. 2019 Nov;29(6):712-720. doi: 10.1111/jon.12643. Epub 2019 Jun 14. J Neuroimaging. 2019. PMID: 31199036
-
Positron emission tomography imaging in dementia.Br J Radiol. 2007 Dec;80 Spec No 2:S160-7. doi: 10.1259/bjr/97295129. Br J Radiol. 2007. PMID: 18445746 Review.
Cited by
-
Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease.Transl Psychiatry. 2013 Feb 19;3(2):e227. doi: 10.1038/tp.2013.11. Transl Psychiatry. 2013. PMID: 23423136 Free PMC article.
-
Neurocognitive trajectory and proteomic signature of inherited risk for Alzheimer's disease.PLoS Genet. 2022 Sep 1;18(9):e1010294. doi: 10.1371/journal.pgen.1010294. eCollection 2022 Sep. PLoS Genet. 2022. PMID: 36048760 Free PMC article.
-
Reference cluster normalization improves detection of frontotemporal lobar degeneration by means of FDG-PET.PLoS One. 2013;8(2):e55415. doi: 10.1371/journal.pone.0055415. Epub 2013 Feb 25. PLoS One. 2013. PMID: 23451025 Free PMC article.
-
Generative FDG-PET and MRI model of aging and disease progression in Alzheimer's disease.PLoS Comput Biol. 2013 Apr;9(4):e1002987. doi: 10.1371/journal.pcbi.1002987. Epub 2013 Apr 4. PLoS Comput Biol. 2013. PMID: 23592957 Free PMC article.
-
Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants.BMC Neurosci. 2020 Sep 4;21(1):36. doi: 10.1186/s12868-020-00586-0. BMC Neurosci. 2020. PMID: 32887544 Free PMC article.
References
-
- Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet. 2006;367:1262–1270. - PubMed
-
- Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985–1992. - PubMed
-
- Silverman DHS, Gambhir SS, Huang HW, et al. Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. J Nucl Med. 2002;43:253–266. - PubMed
-
- Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease: FDG-PET studies in MCI and AD. Eur J Nucl Med Imaging. 2005;32:486–510. - PubMed
-
- Ishii K, Sakamoto S, Sasaki M, et al. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med. 1998;39:1875–1878. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical